Kaplan–Meier curve for estimated median PFS in the DLBCL combined cohort (safety population).
lymphoma, death, DLBCL
LYMPHOMA, DISEASE
PFS is defined as the time from the date of the first study treatment administration to the date of the first documentation of progressive disease or death.The median overall survival (OS) was 8.3 months (95% CI, 3.7–NE) in patients with lymphoma and 3.9 months (95% CI, 2.1–NE) in patients with DLBCL. Overall, 52 patients with lymphoma (42%), including 42 patients in the DLBCL cohorts (47%), died within the time period between the first dose and the last follow-up.Within the DLBCL response-evaluable population (